443 related articles for article (PubMed ID: 27716429)
21. Viral haemorrhagic fever surveillance in Kenya, 1980-1981.
Johnson BK; Ocheng D; Gitau LG; Gichogo A; Tukei PM; Ngindu A; Langatt A; Smith DH; Johnson KM; Kiley MP; Swanepoel R; Isaacson M
Trop Geogr Med; 1983 Mar; 35(1):43-7. PubMed ID: 6684336
[TBL] [Abstract][Full Text] [Related]
22. Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984.
Rodhain F; Gonzalez JP; Mercier E; Helynck B; Larouze B; Hannoun C
Trans R Soc Trop Med Hyg; 1989; 83(6):851-4. PubMed ID: 2559514
[TBL] [Abstract][Full Text] [Related]
23. Lassa fever in children in Sierra Leone, West Africa.
Webb PA; McCormick JB; King IJ; Bosman I; Johnson KM; Elliott LH; Kono GK; O'Sullivan R
Trans R Soc Trop Med Hyg; 1986; 80(4):577-82. PubMed ID: 3810792
[TBL] [Abstract][Full Text] [Related]
24. Antibodies against haemorrhagic fever viruses in Kenya populations.
Johnson BK; Ocheng D; Gichogo A; Okiro M; Libondo D; Tukei PM; Ho M; Mugambi M; Timms GL; French M
Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422
[TBL] [Abstract][Full Text] [Related]
25. [Clinical aspects of viral hemorrhagic fever].
Saijo M
Nihon Rinsho; 2005 Dec; 63(12):2161-6. PubMed ID: 16363689
[TBL] [Abstract][Full Text] [Related]
26. Housing equity for health equity: a rights-based approach to the control of Lassa fever in post-war Sierra Leone.
Kelly JD; Barrie MB; Ross RA; Temple BA; Moses LM; Bausch DG
BMC Int Health Hum Rights; 2013 Jan; 13():2. PubMed ID: 23282054
[TBL] [Abstract][Full Text] [Related]
27. Data set on Lassa fever in post-conflict Sierra Leone.
Shaffer JG; Schieffelin JS; Grant DS; Goba A; Momoh M; Kanneh L; Levy DC; Hartnett JN; Boisen ML; Branco LM; Garry RF;
Data Brief; 2019 Apr; 23():103673. PubMed ID: 30788396
[TBL] [Abstract][Full Text] [Related]
28. Comparison of MagPix Assays and Enzyme-Linked Immunosorbent Assay for Detection of Hemorrhagic Fever Viruses.
Satterly NG; Voorhees MA; Ames AD; Schoepp RJ
J Clin Microbiol; 2017 Jan; 55(1):68-78. PubMed ID: 27795340
[TBL] [Abstract][Full Text] [Related]
29. [Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
Hotta H
Rinsho Byori; 1998 Jul; 46(7):651-5. PubMed ID: 9721531
[TBL] [Abstract][Full Text] [Related]
30. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
[TBL] [Abstract][Full Text] [Related]
31. Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium.
Colebunders R; Van Esbroeck M; Moreau M; Borchert M
Acta Clin Belg; 2002; 57(5):233-40. PubMed ID: 12534129
[TBL] [Abstract][Full Text] [Related]
32. Lassa Fever Natural History and Clinical Management.
Grant DS; Samuels RJ; Garry RF; Schieffelin JS
Curr Top Microbiol Immunol; 2023; 440():165-192. PubMed ID: 37106159
[TBL] [Abstract][Full Text] [Related]
33. Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019.
Shaffer JG; Schieffelin JS; Momoh M; Goba A; Kanneh L; Alhasan F; Gbakie M; Engel EJ; Bond NG; Hartnett JN; Nelson DKS; Bush DJ; Boisen ML; Heinrich ML; Rowland MM; Branco LM; Samuels RJ; Garry RF; Grant DS; The Viral Hemorrhagic Fever Consortium
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33809204
[TBL] [Abstract][Full Text] [Related]
34. Sequence variability and geographic distribution of Lassa virus, Sierra Leone.
Leski TA; Stockelman MG; Moses LM; Park M; Stenger DA; Ansumana R; Bausch DG; Lin B
Emerg Infect Dis; 2015 Apr; 21(4):609-18. PubMed ID: 25811712
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of arthropod-borne viruses and other infectious disease pathogens as the causes of febrile illnesses in the Khartoum Province of Sudan.
McCarthy MC; Haberberger RL; Salib AW; Soliman BA; El-Tigani A; Khalid IO; Watts DM
J Med Virol; 1996 Feb; 48(2):141-6. PubMed ID: 8835346
[TBL] [Abstract][Full Text] [Related]
36. [Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast].
Akoua-Koffi C; Ter Meulen J; Legros D; Akran V; Aïdara M; Nahounou N; Dogbo P; Ehouman A
Med Trop (Mars); 2006 Oct; 66(5):465-8. PubMed ID: 17201291
[TBL] [Abstract][Full Text] [Related]
37. Boosting understanding of Lassa Fever virus epidemiology: Field testing a novel assay to identify past Lassa Fever virus infection in blood and oral fluids of survivors and unexposed controls in Sierra Leone.
Akpogheneta O; Dicks S; Grant D; Kanneh Z; Jusu B; Edem-Hotah J; Kanneh L; Alhasan F; Gbakie M; Schieffelin J; Ijaz S; Tedder R; Bower H
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009255. PubMed ID: 33788861
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to haemorrhagic fever viruses in Madagascar populations.
Mathiot CC; Fontenille D; Georges AJ; Coulanges P
Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626
[TBL] [Abstract][Full Text] [Related]
39. Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.
Gale TV; Horton TM; Grant DS; Garry RF
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005943. PubMed ID: 28922385
[TBL] [Abstract][Full Text] [Related]
40. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone.
Monath TP; Newhouse VF; Kemp GE; Setzer HW; Cacciapuoti A
Science; 1974 Jul; 185(4147):263-5. PubMed ID: 4833828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]